Glucosuria Is Not Always Due to Diabetes

Area of Science:

• Nephrology
• Endocrinology
• Genetics

Background:

• Sodium-glucose cotransporter 2 (SGLT2) mutations are an uncommon genetic cause of glucosuria.
• These mutations can phenotypically mimic the effects of SGLT2 inhibitor medications.
• Understanding these mutations is crucial for differential diagnosis and patient management.

Purpose of the Study:

• To highlight the need for further investigation into the long-term consequences of SGLT2 mutations.
• To emphasize the potential for SGLT2 mutations to predispose individuals to other metabolic and cardiovascular conditions.

Main Methods:

• This study is a review of existing literature and case reports concerning SGLT2 mutations.
• Analysis of clinical data to identify patterns and long-term outcomes associated with SGLT2 mutations.

Main Results:

• SGLT2 mutations present as glucosuria, similar to SGLT2 inhibitor use.
• Potential for development of secondary conditions including renal disease, type 2 diabetes mellitus, and cardiovascular disease.

Conclusions:

• Long-term follow-up and further studies are essential for individuals with SGLT2 mutations.
• Early identification and monitoring may mitigate risks associated with associated comorbidities.